Vivani Medical Statistics
Total Valuation
Vivani Medical has a market cap or net worth of $71.83 million. The enterprise value is $71.31 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, before market open.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Vivani Medical has 55.26 million shares outstanding. The number of shares has increased by 11.21% in one year.
Current Share Class | 55.26M |
Shares Outstanding | 55.26M |
Shares Change (YoY) | +11.21% |
Shares Change (QoQ) | +0.41% |
Owned by Insiders (%) | 39.22% |
Owned by Institutions (%) | 12.36% |
Float | 27.32M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.89 |
P/TBV Ratio | 3.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 1.07.
Current Ratio | 3.41 |
Quick Ratio | 3.13 |
Debt / Equity | 1.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -105.35% and return on invested capital (ROIC) is -35.82%.
Return on Equity (ROE) | -105.35% |
Return on Assets (ROA) | -31.74% |
Return on Capital (ROIC) | -35.82% |
Revenue Per Employee | n/a |
Profits Per Employee | -$533,227 |
Employee Count | 44 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.82% in the last 52 weeks. The beta is 3.51, so Vivani Medical's price volatility has been higher than the market average.
Beta (5Y) | 3.51 |
52-Week Price Change | +31.82% |
50-Day Moving Average | 1.24 |
200-Day Moving Average | 1.49 |
Relative Strength Index (RSI) | 51.20 |
Average Volume (20 Days) | 131,352 |
Short Selling Information
The latest short interest is 754,373, so 1.37% of the outstanding shares have been sold short.
Short Interest | 754,373 |
Short Previous Month | 858,500 |
Short % of Shares Out | 1.37% |
Short % of Float | 2.76% |
Short Ratio (days to cover) | 12.59 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -24.43M |
Pretax Income | -25.37M |
Net Income | -23.46M |
EBITDA | -24.03M |
EBIT | -24.43M |
Earnings Per Share (EPS) | -$0.44 |
Full Income Statement Balance Sheet
The company has $19.65 million in cash and $19.68 million in debt, giving a net cash position of -$33,000 or -$0.00 per share.
Cash & Cash Equivalents | 19.65M |
Total Debt | 19.68M |
Net Cash | -33,000 |
Net Cash Per Share | -$0.00 |
Equity (Book Value) | 18.33M |
Book Value Per Share | 0.33 |
Working Capital | 15.13M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$18.46 million and capital expenditures -$1.00 million, giving a free cash flow of -$19.46 million.
Operating Cash Flow | -18.46M |
Capital Expenditures | -1.00M |
Free Cash Flow | -19.46M |
FCF Per Share | -$0.35 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |